MicroVue™ Mouse PTH ELISA (1-84)

The MicroVue Mouse PTH 1-84 ELISA Kit is for the measurement of PTH in mouse plasma or cell culture media.

Product Specifications

Citations12
Specimen

Plasma or Cell Culture Supernatent, 25 μL

LLOQ0.004 ng/mL
ULOQN/A
Assay Time3.5 hours
Cross Reactivity

Rat

Technical Documents

Ordering Information

For Research Use Only. Not for use in diagnostic procedures.
Catalog Number60-2305
Catalog Number (CE) 
Size96 wells/test
Price (USD)$725.00
Price (EURO)640,00 €
Request an Order

Contact us

US Phone+1 (858) 552 1100
EU Phone+353 (91) 412 474
US Emailcontact-us@quidelortho.com
EU Emailcontact-emea@quidelortho.com

Specifications

Description

The MicroVue Mouse PTH 1-84 ELISA Kit is for the measurement of PTH in mouse plasma or cell culture media.

Size96 wells/test
Form

96 well plate with 12 eight-well strips in a resealable foil pouch

SpecimenPlasma or Cell Culture Supernatent, 25 μL
Limit of Detection (LOD)0.004 ng/mL
Lower Limit of Quantitation (LLOQ)0.004 ng/mL
Upper Limit of Quantitation (ULOQ)N/A
Intra Assay2.4 - 5.6%
Inter Assay5.4 - 5.7%
Standards6
Controls2
Sample Values

N/A

Assay Time3.5 hours
Cross Reactivity

Rat

Storage

Store unopened kit between 2°C to 8°C. Refer to manual for storing individual components

Background

Mouse intact parathyroid hormone (PTH 1-84) is an amino acid polypeptide produced by the parathyroid gland with its biological activity residing in the N-terminal region of the peptide. PTH plays an important role in maintaining the concentration of ionized calcium within the limits needed to achieve normal metabolic functions. When serum calcium levels are decreased the parathyroid gland increases secretion of the hormone which results in increased mobilization of calcium from skeletal reserves into the circulation. When levels of serum calcium are increased the secretion of PTH is reduced.

Citations

TitleYearApplicationsSample SpeciesSampleSample Details

Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice.

2019ELISAMouse

Plasma

N/A

Human Heterozygous ENPP1 Deficiency Is Associated With Early Onset Osteoporosis, a Phenotype Recapitulated in a Mouse Model of Enpp1 Deficiency.

2019ELISAMouse

Plasma

N/A

Feature Article: Altered morpho-functional features of bones in autoimmune disease-prone BXSB/MpJ-Yaa mice.

2019ELISAMouse

Serum

N/A

1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice

2019ELISAMouse

Serum

N/A

1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice

2019ELISAMouse

Urine

N/A

Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.

2018ELISAMouse

Plasma

N/A

The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction

2017ELISAMouse

Plasma

N/A

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

2016ELISAMouse

Serum

N/A

Hypochlorhydria-induced calcium malabsorption does not affect fracture healing but increases post-traumatic bone loss in the intact skeleton

2016ELISAMouse

Serum

N/A

Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia

2016ELISAMouse

Serum

N/A

Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23

2015ELISAMouse

Serum

N/A

Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia

2013ELISAMouse

Serum

N/A

Certificate of Analysis

Showing results for
No results found for